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ABSTRACT
Introduction Various intracanal medicaments have been 
used in cases of chronic apical periodontitis for appropriate 
disinfection of the root canal system to eliminate microbes 
especially from the inaccessible areas. Calcium hydroxide 
is the most common intracanal medicament available in 
various forms, but its effectiveness with or without iodoform 
using microbial culture is unknown. Therefore, our aim is to 
compare the antimicrobial efficacy of Calcipex and Metapex 
in endodontic treatment of teeth presenting with chronic 
apical periodontitis by assessing the bacterial load reduction.
Method and analysis 60 single rooted teeth of patients 
with diagnosis of chronic apical periodontitis will be selected 
and the canals debrided chemomechanically. The patients 
will be randomised into two groups: Calcipex and Metapex. 
The first sample (S1) for bacterial culture will be taken 
before placement of intracanal medicament and the second 
sample (S2) will be taken after 7 days, before final obturation 
from the canal and sent to lab for culture. Colony- forming 
unit will be evaluated. Paired t- test will be used to assess 
difference between antimicrobial efficacies within the group 
of medicaments. Independent sample t- test will be used to 
assess antimicrobial efficacies between groups. Level of 
significance will be kept at 0.05.
Ethics and dissemination Approval from Aga Khan 
University Hospital Ethical review committee is taken. 
Findings will be reported according to the Standard Protocol 
Items for Randomised Trials guidelines. Research findings 
will be disseminated through annual reports, peer- reviewed 
journals and conferences.
Trial registration number NCT04336709.
BACKGROUND
Pulpal necrosis may lead to spread of the 
infection from the pulp to involve the apex of 
the tooth and surrounding bone, which when 
asymptomatic with periapical radiolucency 
on radiograph, is called chronic apical peri-
odontitis.1 2 In order to eliminate the virulent 
bacteria and to overcome the inflammation 
in the root apex, endodontic treatment is 
the treatment of choice. For the long- term 
success of endodontic treatment, complete 
debridement and reduction of the bacterial 
count using mechanical cleaning and chem-
ical irrigation seems to be necessary.3 Yet 
there is no definitive evidence in the litera-
ture regarding any of the chemomechanical 
debridement methods resulting in complete 
elimination of bacteria from the root canal 
system.4 5 The complex anatomy of the root 
canal system and presence of many in- acces-
sible areas like lateral canals and dentinal 
tubules, makes elimination of bacteria from 
the infected root canal system challenging.6
The bacteria that survived in the root canal 
system might multiply between the appoint-
ments or following obturation often reach the 
previous pathogenic level, thus ending up in 
endodontic failure.7 In order to eliminate the 
remaining bacteria, various intracanal medica-
ments have been used widely. However, there 
is lack of consensus over their use and effi-
cacy.8 According to Trope et al9, use of calcium 
hydroxide (CH) dressing in periapical infection 
reduced the percentage of bacteria upto 90% 
to 100%; and thus, significantly improved peri-
apical healing.
Strengths and limitations of this study
 ► Our study is first of its kind to determine efficacy be-
tween Calcipex and Metapex using bacterial count.
 ► Bacterial culture (colony- forming unit/mL) is one of 
the accurate methods in determining presence of 
viable bacteria and medicament efficacy.
 ► Adequate randomisation, blinding and standardised 
protocols will be followed to obtain optimum result 
outcome.
 ► There may be lost to follow- up, flare- ups or unexpect-
ed results.
 ► It is a single- centred study, which may be a limitation 
and multiple medicaments may be compared in future. 
More specific methods like RT- PCR could be used.
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CH is the most commonly used intracanal medicament 
that is employed between root canal treatment sessions and 
available in different combinations. Calcipex (CalcipexII, 
Nishika, Yamaguchi, Japan) is a water- based CH paste but 
it is also available with additional substances like iodoform 
in oil vehicle (Metapex, Meta Biomed, Korea) which is 
claimed to enhance its antimicrobial activity against Entero-
coccus faecalis.10–12
Multiple studies have been conducted to evaluate the 
effect of various types of CH- based medicaments.13–16 
Cwikla et al compared CH mixed with water, CH mixed 
with iodine- potassium iodide, and CH mixed with iodo-
form and silicone oil (Metapex). He concluded that 
Metapex is the most effective dentinal tubule disinfec-
tant.17 On the contrary, Estrela et al10 examined the 
antimicrobial efficacy of CH with certain vehicles and 
concluded that the vehicles did not influence the anti-
microbial activity of CH.18 Estrela et al10 in another study 
concluded that addition of iodoform does not improve 
the antimicrobial efficacy of CH- saline solution. Whether 
CH with iodoform is more effective than CH alone against 
endodontic pathogens is yet to be established.
There are several methods to evaluate the antimicrobial 
effectiveness of intracanal medicaments. PCR is the most 
sensitive method for microbial species identification with 
less interference but it is costly and not readily available 
in dental clinics.19 In order to evaluate the true reduc-
tion in microbial load from the infected canals, micro-
bial culture is a predictable and convenient tool. There is 
a paucity of literature related to the effectiveness of CH 
with or without iodoform using microbial culture.
Thus, this study aims to evaluate the antimicrobial 
effectiveness of interappointment intracanal medica-
ment with either CH alone (Calcipex) or CH with iodo-
form (Metapex) for the treatment of infected root canals 
of teeth diagnosed with chronic apical periodontitis by 
assessing the bacterial load reduction.
Alternate hypothesis
There is difference in the antimicrobial efficacy of 
Calcipex and Metapex in root canals of teeth presenting 
with chronic apical periodontitis.
Study objectives
To compare the antimicrobial efficacy of Calcipex and 
Metapex in endodontic treatment of teeth presenting 
with chronic apical periodontitis
Trial design
Two- arm parallel design, randomised controlled trial.
METHODS AND ANALYSIS
Study setting and duration
Dental Clinics, Aga Khan University Hospital (AKUH), 





Sample size was calculated using WHO sample size calcu-
lator (Software V.2.0).20 Dutta et al13 showed that the 
population mean and SD of teeth treated with CH- based 
intracanal medicaments were 50.3±13 colony- forming 
unit (CFU)/mL. Keeping the absolute precision at 0.05 
and level of confidence at 95%, the required sample size 
turned out to be 26 teeth. The sample is inflated to 30. 
As we have two groups, therefore, a total of 60 teeth will 
be taken.
Patient and public involvement
Patients will not be involved in the recruitment and 
conduct of study. They only will participate as research 
participants. They will be informed about the details and 
research being conducted and then consent signed. The 
consent has all the information mentioned regarding the 
study. The results of the study will be emailed to the study 
participants at the end of the study.
Sample selection
Inclusion criteria
 ► Single rooted human permanent teeth with single 
root canal.
 ► Clinically diagnosed with chronic apical periodontitis.
 ► No history of antibiotics use in last 3 months.
Exclusion criteria
 ► Periodontally compromised teeth with grade III 
mobility.
 ► Endodontically non- salvageable teeth.
 ► Immunocompromised patients/systemic illness.
 ► Excessive root resorption.
 ► History of allergy to CH or iodoform.
 ► Endodontic retreatment cases.
Interventions
Drugs: Intracanal medicaments
1. Calcipex (CalcipexII, Nishika, Yamaguchi, Japan).





Frequency—used once on first day only till canal fills.
Composition—water- based CH paste without radio 
contrast agent (barium sulfate).
Packaging—(1 syringe of Calcipex Plain II (1.8 g), two 
needles of Nishika Spin with two needle caps).
Storage requirement—room temperature (1°C–30℃).
2. Metapex (Meta Biomed, Korea)
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Frequency: used once on first day only till canal fills.
Composition—premixed oil- based paste composed of 
CH with Iodoform and silicon oil.
Packaging—2.2g paste in one syringe. Twenty dispos-
able tips. One ring rotator for direction control of the 
tip.
Storage requirement—room temperature (1°C–30℃).
These intracanal medicaments will be placed inside the 
root canals at one point in time.
Outcomes
Antimicrobial efficacy (time frame: 7 days).
Antimicrobial efficacy of intracanal medicament as 
measuring using CFU/mL via bacterial culture. The 
higher CFU/mL suggests more bacterial colonies. We 
expect the counts to reduce after using the intracanal 
medicament
Participant recruitment
All the patients visiting the dental clinics of Aga Khan 
University Hospital will be included who fulfil our inclu-
sion criteria and give consent.
Randomisation, blinding and treatment allocation
The selected subjects will be assigned to one of the two 
study groups only known to the researcher who is not 
involved in the outcome assessment using block randomi-
sation (figure 1). This would be facilitated by clinical trial 
unit (CTU). The block size would be 6.
Group A (control group)—Calcipex group (n=30).
Group B (intervention group)—Metapex group 
(n=30).
The sample in Eppendorf Tubes will be sent in a zip 
lock bag to the microbiology laboratory labelled with 
either group A or B. Patient, analyser and the statisti-
cian will be blinded about the intervention groups. The 
recruitment of patients, collection of samples and place-
ment of intracanal medicament will be performed by a 
single investigator. The investigator placing the intracanal 
medicament cannot be blinded as the colour of the 
two medicaments is different. In case of adverse event, 
unblinding will be done
Data collection procedure
Approval from AKUH Ethical review committee was 
taken. All patients falling in inclusion criteria will receive 
detailed information regarding the study, its advantages, 
benefits and risks. Informed consent will be obtained by a 
third investigator not involved in data/sample collection. 
Ethical review committee approval is obtained. (Ethics 
Review Committee (ERC), Ref No: 2020-0304-9040).
Training of the examiner
The participating investigator with at least 4 years of prior 
experience will be trained on the development of the 
trial, case selection, measurement techniques, sample 
Figure 1 Flow diagram. CFU, colony- forming unit.
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The tooth diagnosed with chronic apical periodontitis 
will be anaesthetised using 2% lidocaine (with 1:100 000 
epinephrine) and isolated with the rubber dam. Access 
opening will be performed using high and low speed 
round bur. Coronal and radicular necrotic pulp will be 
extirpated using barbed broaches. The root canal will be 
initially prepared by using hand K- files (Endoflex; K- File, 
Size 8–20, NiTi) with quarter turn and pull motion. A 
23- gauge side vented needle will be used to deliver 1 mL 
of sodium hypochlorite for irrigation after each instru-
ment size. The working length will be established with 
an apex locator and confirmed by the periapical radio-
graphs. Chemomechanical preparation will be completed 
using Protaper Next (Dentsply; Sirona, USA) depending 
on both root anatomy and initial diameter of the root 
canal. The preparation will be completed in the same 
appointment in all cases. After completion of the prepa-
ration, the canals will be irrigated with saline and dried 
with paper points. A sterile paper point (size 20; EZ Endo, 
USA) will be inserted to the confirmed working length of 
the canal, and retained in position for 60 s for sampling18 
(S1) to soak all the canal contents. Afterwards, the paper 
point will be gently removed and placed in an Eppendorf 
tube (5 mL) containing Brain Heart Infusion Broth and 
sent directly to the microbiology laboratory for microbial 
cultivation.
In group A, the canal will be medicated with Calcipex 
(CalcipexII, Nishika, Yamaguchi, Japan) which will be 
placed by means of lentulo spiral fillers at low speed of 
about 5000 rpm21 and packed with a cotton pellet at 
the level of canal entrance. Access cavity will be filled 
with a temporary resin based filling material, Dia- Temp 
(DiaDent Europe BV, Almere, Netherlands) which has the 
least microleakage and best sealing ability.22 In group B, 
the canal will be medicated with Metapex (Meta Biomed, 
Korea) using the same protocol as mentioned above.
Second visit
Patient will be followed up on 7±3 days as the effect of 
medicament is at its maximum at seventh day and longer 
placement of the medicament may make the tooth brittle 
and prone to fracture.23 The tooth will be isolated and 
the protocol will be followed the same way as described 
before. The temporary filling will be removed and the 
paste carried out of the canal by using sterile file and irri-
gated with normal saline to wash out the medicament. 
A postmedication sample will be taken with the help of 
sterile paper point in both groups as described previously 
(S2). The canals will be then obturated with gutta- percha 
and CH sealer (Sealapex, Kerr Dental, USA) by lateral 
compaction technique. A definitive restoration will be 
placed subsequently.
Outcome assessment
It will be done in the microbiology laboratory on the basis 
of CFU/mL.
Microbiology lab protocol
The paper point will be taken out from the container and 
inserted into the other container filled with enhancement 
medium of Brain- Heart Infusion Broth (BHIB), vortexed 
for 60 s to remove all bacteria and spread on BHIB. One 
mL of BHIB will be added with 1 mL NaCl 0.9%, diluted 
and repeated in five series until it reached 105 CFU 
bacteria. Each spiral dilute inoculate each dilution in a 
sterile petri dish containing blood agar and incubated 
anaerobically for 24 hours at 37°C in CO2 incubator. After 
24 hours incubation period, the bacterial growth will be 
counted and CFU/mL will be calculated.
Data analysis procedure
Data will be analysed using SPSS V.23.0. Mean and SD 
of continuous variable will be computed. Frequency 
distribution and proportion of categorical variables will 
be determined. Paired t- test will be used to assess differ-
ence between antimicrobial efficacies within the group of 
medicaments. Independent sample t- test will be used to 
assess antimicrobial efficacies between groups. Level of 
significance will be kept at 0.05.
Data monitoring
Data collection and maintenance would be reviewed 
timely by the prinicpal investigator and CTU.
Adverse events
The chances of adverse events in healthy patients are 
almost negligible. The product- related adverse events 
would be managed, reported and recorded to ERC within 
a specified period of time.
Ethical considerations
Ethical approval is obtained from institutional ERC. 
Patients who fulfilled the inclusion criteria will receive 
detailed information regarding the study and only those 
participants will be recruited who will sign the written 
consent form. The study will be conducted according to 
the World Medical Association’s Declaration of Helsinki 
and the principles of Good Clinical Practice (GCP). Any 
subsequent protocol amendments will be submitted to 
ERC and regulatory authorities for approval. The trial 
will be conducted in compliance with regulations, partic-
ularly specifying pharmacovigilance reporting and a copy 
of final study report will be submitted to ERC.
Dissemination plan
No publication related to this study has been published 
or submitted to any journal. Findings will be reported 
according to the Standard Protocol Items for Randomised 
Trials guidelines. Research findings will be disseminated 
through annual reports. Main study protocol amend-
ments will be reported when findings are disseminated.
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DISCUSSION
There is no risk involved in this study as the study is based 
on routine procedure of endodontic treatment. It will be 
a benefit for future patients which will help us to decide 
which intracanal medicament is more effective to use in 
infected canals.
The data will be collected on case report form (CRF) 
on first and second visit. The CRF has been developed 
by investigator and reviewed by experts of the field. Data 
will be stored in a password- protected database. To assure 
quality, data will be double checked to avoid discrepancies 
and errors. The information provided by the participant 
will remain confidential. Nobody except investigators will 
have access to it. Participants’ name and identity will not 
be disclosed at any time. However, the data may be seen 
by ethical review committee, DSMB or any local regula-
tory body. As per GCP and other guidelines, data will be 
retained for 3 years.
Recruitment of patients is started and will be completed 
by the end of December 2020.
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